Jorge da Silva

Jorge Santos da Silva is the Founder and Chief Executive Officer of MoonLake Immunotherapeutics AG, a company focused on developing innovative treatments for inflammatory diseases using Nanobody technology. He has held this position since July 2021 and is based in Zug, Switzerland.1

Professional Background

Before founding MoonLake, Santos da Silva was a Senior Partner at McKinsey & Company from 2014 until July 2021, where he specialized in advising healthcare and biotechnology sectors. Prior to that, he worked as a Management Consultant at McKinsey from 2007 to 2013.1

Santos da Silva also has a strong academic background in neuroscience. He completed his PhD in Neurobiology at the Università degli Studi di Torino, focusing on neuronal development and cytoskeletal mechanisms. Additionally, he has held research positions at Cold Spring Harbor Laboratory, where he led research on brain development and neurotransmitter roles.1

Education

• PhD in Neurobiology: Università degli Studi di Torino (2000-2004)
• MSc in Neurobiology: European Molecular Biology Laboratory (1997-1998)
• BSc/MSc in Molecular Biology: The University of Glasgow (1996-2000)

Languages

Santos da Silva is multilingual, fluent in Portuguese, Spanish, Italian, and English, with professional proficiency in German and limited proficiency in French.1

His leadership at MoonLake Immunotherapeutics has been marked by significant milestones, including the initiation of clinical trials for their investigational treatments.23